Baxter (NYSE:BAX) and Direct Relief announced today that they are launching a three-year program awarding funding to health centers and free and charitable clinics that are working to improve diabetes outcomes for patients. The program, Transformative Innovation Awards for Community Health: Incorporating Nutrition to Improve Diabetes Health Outcomes, will award $750,000 to the centers and clinics, […]
Baxter throws $500m behind CMS push for dialysis innovation
Baxter (NYSE:BAX) officials apparently think their company can benefit from a Trump administration and CMS proposal to provide extra reimbursement for new and innovative dialysis equipment and supplies. Just days ago, CEO Joe Almeida told analysts in an earnings call that the company planned to invest $500 million to significantly increase production capacity and meet new […]
Baxter ticks up on Q2 beats
Baxter (NYSE:BAX) shares gained in pre-market trading today after the company posted second-quarter numbers that topped the consensus forecasts for both sales and earnings. The Chicago-area healthcare giant reported profits of $343 million, or 66¢ per share, on sales of $2.84 billion for the three months ended June 30, amounting to flat sales and earnings growth […]
Trump reveals plan to overhaul kidney disease care
The Trump administration yesterday revealed its plan to overhaul the way kidney disease is treated in the U.S., looking to increase early detection and emphasize transplants and home hemodialysis instead of in-clinic treatment via executive order. Shares of dialysis providers DaVita Healthcare (NYSE:DVA) and Fresenius (NYSE:FMS) took a hit earlier this week on news of the changes. The executive […]
Baxter launches telehealth service for home dialysis treatments
Baxter (NYSE:BAX) today announced that it has launched its Sharesource 2.0 telehealth clinical portal. Sharesource is a telehealth platform for home dialysis the helps healthcare providers get better insight into a patient’s home peritoneal dialysis (PD) treatments. The system has helped manage more than 7 million PD treatments in more than 40 countries, according to the […]
Baxter closes $1.7B senior note offering
Baxter (NYSE:BAX) has closed an offering of senior notes worth approximately $1.68 billion (EU €1.5 billion), according to a recently posted SEC filing. The Deerfield, Ill.-based company said that it offered $841.3 million (EU €750 million) in 0.4% senior notes due 2024 and $841.3 million (EU €750 million) in 1.3% senior notes due 2029. The senior notes […]
Mom knows best: How mothers inspired medtech’s top CEOs
On Sunday, we Americans honor our mothers. The flowers, brunches, jewelry and other tokens can’t come close to repaying the women who raised us, fed us, tended our wounds, cleaned up our messes, made us clean up our own, and taught us how to be in the world. Business leaders often talk about their fathers’ […]
DaVita taps Javier Rodriguez as CEO | Personnel Moves – April 29, 2019
DaVita Healthcare (NYSE:DVA) said today that its board of directors unanimously elected Javier Rodriguez to succeed Kent Thiry as its new CEO, effective June 1. The Denver-based company said that former CEO Thiry will transition to serve as executive chairman of the board, and that the announcement comes as part of a multi-year succession planning process. […]
Baxter shares dip despite Q1 earnings beat
Shares in Baxter (NYSE:BAX) fell today despite the medical device maker beating expectations on Wall Street with its first quarter 2019 earnings results. The Deerfield, Ill.-based company posted profits of $347 million, or 66¢ per share, on sales of approximately $2.63 billion for the three months ended March 31, seeing the bottom line shrink 10.8% while […]
ConvaTec taps Bitar as CEO | Personnel Moves – March 26, 2019
ConvaTec (LON:CTEC) said today it tapped Karim Bitar as its new CEO, set to take the position on September 30. Prior to joining the U.K.-based medtech company, Bitar served as CEO of agricultural biotech company Genus, holding the corner office position for approximately eight years. Before his time with Genus, Bitar spent 15 years in various […]
Baxter, Biomérieux ink acute kidney injury biomarker dev deal
Baxter (NYSE:BAX) said today that it inked a partnership deal with Biomérieux looking to develop biomarkers to identify acute kidney injury. The partnership was announced at the International Symposium on Intensive Care and Emergency Medicine, Deerfield, Ill.-based Baxter said. Both companies said they hope to develop the biomarkers to help rapidly identify and inform treatment of acute […]
- 1
- 2
- 3
- …
- 28
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube